Canine Arthritis Market

Canine Arthritis Market - Size, Share, Outlook, and
Opportunity Analysis, 2018 – 2026
Canine arthritis is a major ailments seen in the middle aged to older dogs. Most common
causes of canine arthritis include, cartilage deficits, previous injuries such as anterior cruciate
ligament, poor nutrition, trauma after a car accident, penetration of joint by a sharp object, or
bite, infection in the joint, stresses on the joint, disruption of cartilage, bone, synovial
membranes, and ligaments that support a joint, bacteria spread through the blood supply,
fungus, and tick-borne disease. Symptoms of canine arthritis include, lameness and stiffness,
slow gait, difficulty in rising from rest, lethargy and tendency to sleep more, urinating indoors,
muscle atrophy, swelling, pain, licking of joints, gain or loss of weight, nervous or aggressive
behavior, and reluctance to jumping.
For In depth Information Get Sample Copy of this Report @
https://www.coherentmarketinsights.com/insight/request-sample/2433
Canine Arthritis Market – Drivers
Factors such as high adoption of pets by common people, increasing expenditure by consumers
on veterinary care, and increasing number of approvals for veterinary medicines are expected to
drive growth of the canine arthritis market. For instance, in March 2016, USFDA approved
Galliprant — an animal drug for osteoarthritis in dogs. Galliprant is a prostaglandin E2 (PGE2)
EP4 receptor antagonist, a non-cyclooxygenase inhibiting, non-steroidal anti-inflammatory drug
(NSAID) and is intended to control pain and inflammation associated with osteoarthritis in dogs.
The application for Galliprant was sponsored by Aratana Therapeutics.
Furthermore, increasing initiatives by professional business services to offer support for pet care
is expected to propel the market growth. For instance, in January 2019, the International
Boarding & Pet Services Association (IBPSA) appointed one Chief Operating Officer along with
three new advisory boards to bring an additional and invaluable experiences of pet care
business to IBPSA and its members.
Canine Arthritis Market – Regional Analysis
On the basis of region, the global canine arthritis market is segmented into North America,
Latin America, Europe, Asia Pacific, Middle East, and Africa.
North America is expected witness significant growth in the global canine arthritis market,
owing to presence of major players and new product launches in the region. For instance, in
July 2018, CBD DOG Health — a pet wellness company — launched three new products
containing healing cannabinoids at the SuperZoo Pet Industry Trade Show in Las Vegas, U.S.
The three new products include, lines of CBD Oils, CBD Topicals, and CBD Treats. CBD Oil
offers products namely CALM, EASE, and HEAL varieties. It contains full spectrum hemp oil
and CBD. EASE Oil is a proprietary blend of curcumin-rich Turmeric and Frankincense. It offers
relief from aches and pains, inflammation, joint pain, arthritis, and intestinal disorders in pets.
Moreover, increasing adoption of pets in North America is also expected to boost growth of the
canine arthritis market. For instance, in 2017-2018, National Pet Owners Survey was conducted
by Ipsos, Inc., and according to the survey, pet ownership in the U.S. households stands at 68%
as compared to 48% in 2016.
Report includes chapters which deeply display the following deliverable about industry :
• Canine Arthritis Market Research Objective and Assumption
• Canine Arthritis Market Purview - Report Description, Executive Summary, and Coherent
Opportunity Map (COM)
• Canine Arthritis Market Dynamics, Regulations, and Trends Analysis - Market Dynamics,
Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system Launch/Approvals,
Value Chain Analysis, Porter’s Analysis, and PEST Analysis
• Global Canine Arthritis Market, By Regions
• Canine Arthritis Market Competition by Manufacturers including Production, Share, Revenue,
Average Price, Manufacturing Base Distribution, Sales Area and Product Type.
• Canine Arthritis Market Manufacturers Profiles/Analysis including Company Basic Information,
Manufacturing Base and Its Competitors.
• Canine Arthritis Market Manufacturing Cost Analysis including Key Raw Materials and Key
Suppliers of Raw Materials.
• Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials
Sourcing and Downstream Buyers
• Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market
Positioning and Distributors/Traders List.
• Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer
Preference Change and Economic/Political Environmental Change.
• Canine Arthritis Market Forecast including Production, Consumption, Import and Export
Forecast by Type, Applications and Region.
• Research Findings and Conclusion
Key players operating in the global canine arthritis market include, Elanco (Eli Lilly and
Company), Boehringer Ingelheim, Zoetis Inc., Vetoquinol S.A., Bayer AG, Aratana Therapeutics
Inc., Norbrook Laboratories Limited, VetStem Biopharma, and Dechra Pharmaceuticals Plc., and
CBD DOG Health.
Browse Complete Report For More Information @
https://www.coherentmarketinsights.com/ongoing-insight/canine-arthritis-market-2433
Canine Arthritis Market – Taxonomy
By Medication Type
Non-Steroidal Anti-Inflammatory Drugs (NSAID’s) ,Corticosteroids ,Opioid Pain Relievers ,Others
By Distribution Channel
Veterinary Hospitals & Clinics ,Retail Pharmacies ,Online Pharmacies
By Region
North America ,Europe ,Asia Pacific ,Latin America ,Middle East ,Africa
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering actionready syndicated research reports, custom market analysis, consulting services, and competitive
analysis through various recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]

Canine arthritis is a major ailments seen in the middle aged to older dogs.